Carevix, approved for use by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), has been designed to minimise pain and reduce bleeding during intrauterine procedures such as coil-fitting and endometrial biopsies. Traditional tenaculum forceps—still commonly used—are known to cause discomfort, fear, and sometimes trauma for patients.

Peterborough City Hospital, part of the North West Anglia NHS Foundation Trust, became the first hospital in the UK to adopt Carevix in 2024 through the Carevix Ambassador Program. This initiative brought together 21 centres of excellence across 9 countries to evaluate the device in real-world settings.

Results from the program showed high satisfaction among both clinicians and patients, with 96% of clinicians finding Carevix easy to use and 94% overall patient satisfaction, according to the Carevix Ambassador Program Report 2024–2025.